Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Mar;26(2):117-24.
doi: 10.1007/BF03013780.

In vivo neutron activation analysis for bone calcium (INVAA) in malignant hyperthermia susceptible patients

In vivo neutron activation analysis for bone calcium (INVAA) in malignant hyperthermia susceptible patients

B A Britt et al. Can Anaesth Soc J. 1979 Mar.

Abstract

Some non-rigid Malignant Hyperthermia Susceptible (MHS) patients have a greater than normal incidence of fractures. Radiologically their long bones are slightly thinner than normal. Excessive numbers of caries because of thin dental enamel may also be present. The Malignant Hyperthermic (MH) defects thus appears to involve cells of bone appendages as well as of muscle. We have measured the concentration of calcium in bone by neutron activation analysis and have found it to be reduced in both non-rigid and rigid malignant hyperthermia susceptible patients. The reductions were particularly marked for the non-rigid patients. Bone calcium concentrations were lower in males than in females and in those under 16 and over 60 years of age. This is additional evidence is favour of the hypothesis that malignant hyperthermia is a widespread defect affecting tissues and organs throughout the body.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Fed Proc. 1973 Sep;32(9):1944-50 - PubMed
    1. Metabolism. 1976 Jan;25(1):33-40 - PubMed
    1. Clin Orthop Relat Res. 1970 Mar-Apr;69:101-17 - PubMed
    1. Ann Clin Biochem. 1976 Nov;13(6):518-39 - PubMed
    1. J Nucl Med. 1973 Jul;14(7):502-6 - PubMed